Additionally, upregulation of miR-193a-3p can modulate serine/arginine-rich splicing factor 2 (SRSF2) expression, inhibit mitochondrial-dependent cellular apoptosis, and confer resistance to cisplatin in gastric cancer cells (Lee et al., 2019). This evidence concerns the gene SRSF2 and gastric cancer.